U.S. Commercial Services Stock News

NYSE:RLJ
NYSE:RLJHotel and Resort REITs

How Investors Are Reacting To RLJ Lodging Trust (RLJ) Sliding From Profit To Loss On Higher Revenue

RLJ Lodging Trust has reported first-quarter 2026 results, with sales rising to US$275.26 million and total revenue to US$339.98 million, but shifting from a US$3.36 million net profit a year earlier to a small US$0.141 million net loss. This move into a slight loss, despite higher revenue and against a backdrop of urban market cost pressures, raises questions about how effectively the company is converting its top-line growth into sustainable profitability. We’ll now examine how this move...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Assessing Kodiak AI (KDK) Valuation After Mixed Short And Long Term Share Price Performance

Kodiak AI stock: what recent performance tells you Kodiak AI (KDK) has drawn attention after a mixed stretch in the stock, with a small single day decline, a drop over the past week, a gain over the past month, and weaker returns over the past year. See our latest analysis for Kodiak AI. With the share price at $8.35, Kodiak AI’s 30 day share price return of 12.53% contrasts with a year to date share price return of 22.90% and a 1 year total shareholder return of 25.84%. This suggests recent...
NYSE:ARW
NYSE:ARWElectronic

Do Earnings Revisions And Vanguard’s Stake Shift the Bull Case For Arrow Electronics (ARW)?

In recent weeks, Arrow Electronics has attracted attention as earnings estimates edged higher and research firm Zacks assigned the stock a Rank #2 (Buy) with a Momentum Style Score of B, alongside new SEC filings showing Vanguard entities holding passive stakes above 5% of outstanding shares as of March 31, 2026. This combination of incremental earnings upgrades, favorable momentum indicators, and sizeable passive institutional ownership highlights shifting sentiment toward Arrow’s...
NYSE:PMT
NYSE:PMTMortgage REITs

A Look At PennyMac Mortgage Investment Trust’s Valuation After Launching The Team USA Athlete Mortgage Program

Why the new Team USA program matters for PennyMac Mortgage Investment Trust (PMT) PennyMac Mortgage Investment Trust (PMT) is in focus after launching the Welcome Home: Athlete Mortgage Program with PennyMac Financial Services. The program targets Team USA athletes with tailored lending support, benefits, and education. See our latest analysis for PennyMac Mortgage Investment Trust. The Athlete Mortgage Program arrives as PMT’s share price trades at US$12.33, with a 30 day share price return...
NYSE:CUZ
NYSE:CUZOffice REITs

Impairment-Driven Loss Amid Strong Leasing Might Change The Case For Investing In Cousins Properties (CUZ)

Cousins Properties reported first-quarter 2026 results on April 29, 2026, with revenue rising to US$263.11 million while moving from net income of US$20.9 million a year earlier to a net loss of US$24.86 million, largely due to a US$36.6 million impairment on its One Eleven Congress asset. Despite the accounting loss, the company showed resilient operations with strong Sun Belt leasing activity, higher occupancy, an increase in funds from operations guidance, and an expanded US$500 million...
NYSE:SJM
NYSE:SJMFood

The Bull Case For J. M. Smucker (SJM) Could Change Following Divergent Analyst Calls And Vanguard Stake Learn Why

In recent days, several major banks updated their views on J. M. Smucker, with Morgan Stanley and Stifel reiterating cautious stances while BTIG began coverage with a more optimistic outlook focused on the company’s coffee business and changing consumer landscape. At the same time, Vanguard disclosed a sizeable passive ownership stake of more than 7 million shares, underlining continued institutional interest in the stock despite differing analyst opinions on its prospects. We’ll now look at...
NasdaqGS:SBRA
NasdaqGS:SBRAHealth Care REITs

A Look At Sabra Health Care REIT (SBRA) Valuation After Its Recent Share Price Momentum

Performance snapshot and why Sabra might be on your radar Sabra Health Care REIT (SBRA) has quietly put together a solid run, with the stock up about 2.5% over the past month and roughly 11% in the past 3 months. For income focused investors watching healthcare real estate, that move, combined with a market value of about US$5.1b and reported annual revenue of US$815.664m, may prompt a closer look at what is driving sentiment. See our latest analysis for Sabra Health Care REIT. At a share...
NYSE:WH
NYSE:WHHospitality

Is It Time To Reassess Wyndham Hotels & Resorts (WH) After Recent Share Price Swings?

If you are wondering whether Wyndham Hotels & Resorts stock still offers value after recent swings, you are not alone. The share price closed at US$80.84, with a 5.3% decline over the last 7 days and a 1.6% decline over 30 days, while the stock shows a 7.4% return year to date, a 1.9% decline over 1 year, 26.8% over 3 years, and 20.8% over 5 years. Recent headlines around Wyndham have focused on its position in the hotel and resort industry and how investors are weighing the balance between...
NYSE:WCN
NYSE:WCNCommercial Services

Waste Connections’ Acquisition Push, AI Pricing And Capital Returns Might Change The Case For Investing In WCN

In the first quarter of 2026, Waste Connections reported higher sales of US$2,370.63 million but lower net income of US$219.34 million year over year, while maintaining its regular US$0.35 quarterly dividend and continuing share repurchases under its existing buyback program. Management also signaled an “above-average” year for acquisitions, citing a robust pipeline including about US$100 million in annualized revenue from deals expected to close by early third quarter, alongside early gains...
NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Quantum Computing Stocks For 2026 If You Expect Real Cash Flows

Quantum computing is moving from theory to tangible products at the same time as investors are dealing with higher inflation, elevated bond yields and energy related uncertainty. In this setting, some prefer themes where long term research and intellectual property matter as much as near term growth. The Quantum Computing Stocks screener focuses on companies working on hardware, software and research around quantum algorithms and superconducting qubits. It can help you quickly narrow a...
NasdaqGS:NEOG
NasdaqGS:NEOGMedical Equipment

A Look At Neogen’s (NEOG) Valuation As Recent Share Price Move Highlights Mixed Return History

Neogen (NEOG) came into focus after a recent move in its share price, with the stock last closing at $9.53. For investors, that price helps frame the discussion around value and expectations. See our latest analysis for Neogen. That recent move sits within a mixed picture, with a strong year to date share price return of 36.14% and a 1 year total shareholder return of 68.97% contrasting with a 3 year total shareholder return of 44.46% and a 5 year total shareholder return of 79.38%. This...
NYSE:BXP
NYSE:BXPOffice REITs

Is Boston Properties (BXP) Offering Value After Recent Share Price Swings?

Wondering whether BXP at around US$59.37 is offering value or just value traps? This article breaks down what the current price might really mean for you. The stock has recently shown mixed returns, with a 2.3% gain over the last week and 14.7% over the last month, set against a year to date return of a 12.5% decline and a 1 year return of a 3.8% decline. Over the longer term, the picture is uneven, with a 37.9% gain across 3 years contrasted by a 29.0% decline over 5 years. This can leave...
NasdaqGS:GLXY
NasdaqGS:GLXYCapital Markets

If Bitcoin And AI Both Win These Cryptocurrency Stocks Could Surprise

Crypto and blockchain are back in focus as investors look for assets that can handle higher energy costs, sticky inflation risks, and shifting central bank plans. With AI-related demand supporting parts of global trade and payment systems under pressure from geopolitical tension, the broader digital infrastructure story is still evolving. The Top Cryptocurrency and Blockchain Stocks screener cuts through the noise by highlighting companies directly linked to this theme, without relying on...
NasdaqGS:COHU
NasdaqGS:COHUSemiconductor

Cohu (COHU) Valuation Check After Upgraded 2026 Outlook And Strong AI And High Performance Computing Momentum

Cohu (COHU) gave investors fresh data to work with after first quarter 2026 results, combining higher semiconductor test demand tied to AI and high performance computing with updated guidance and a larger opportunity pipeline. See our latest analysis for Cohu. Those stronger AI and high performance computing headlines have arrived alongside a sharp re-rating, with an 85.25% year to date share price return and a very large 1 year total shareholder return, even after a recent 3.72% 1 day...
NasdaqGM:MAAS
NasdaqGM:MAASInsurance

Assessing Maase (MAAS) Valuation After A Sharp Multi‑Month Share Price Surge

Recent price action and business snapshot Maase (MAAS) has drawn investor attention after a 63% share price move over the past month and 58% over the past 3 months, prompting a closer look at its current fundamentals. The company provides technological intelligence and capital investment services in China through a technology-driven independent financial service platform and independent wealth management services. It reports revenue of CN¥3.483 and a net loss of CN¥1.775. See our latest...
NYSE:CRL
NYSE:CRLLife Sciences

How Charles River’s Expanded Rat IVF Platform Could Reshape CRL’s Preclinical Services Mix and Investor View

In April 2026, Charles River Laboratories International launched an enhanced in vitro fertility (IVF) service bundle for rat models, combining embryo transfer, cryopreservation, and colony rederivation to help research teams accelerate preclinical programs across oncology, neurology, cardiology, and metabolic disease while easing breeding bottlenecks. This IVF expansion deepens the company’s Genetically Engineered Model Services offering, highlighting how specialized reproductive...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

A Look At BeOne Medicines (ONC) Valuation After FDA Priority Review And New HH160 Collaboration

BeOne Medicines (ONC) has drawn fresh attention after the FDA granted Priority Review to a supplemental Biologics License Application for TEVIMBRA with ZIIHERA and chemotherapy in advanced HER2-positive gastroesophageal cancers, alongside a global HH160 collaboration. See our latest analysis for BeOne Medicines. Despite the FDA Priority Review for TEVIMBRA and the new HH160 collaboration, the share price return has softened recently. The 30-day share price return is 5.45% and the 90-day share...
NYSE:R
NYSE:RTransportation

How Ryder’s Dividend Hike, Buyback Plan, and Higher 2026 EPS Guidance Will Impact Ryder System (R) Investors

Ryder System’s board recently declared a regular quarterly cash dividend of US$0.91 per share to be paid on June 19, 2026, and authorized a new share repurchase plan of up to 2.0 million shares running through May 1, 2028. These moves, alongside first-quarter earnings that prompted higher full-year 2026 EPS guidance, underline management’s emphasis on disciplined capital deployment and shareholder returns supported by a largely contract-based business model. With Ryder increasing its 2026...